57790-51-9

Basic information

• Product Name: 4-benzamidophenyl-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoate
• Synonyms: 4-benzamidophenyl-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoate
• CAS NO: 57790-51-9
• Molecular Weight: 549.708
• Mol File: 57790-51-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-benzamidophenyl-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-benzamidophenyl-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoate(57790-51-9)
• EPA Substance Registry System: 4-benzamidophenyl-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoate(57790-51-9)

Safety Data

• Hazardous Substances Data: 57790-51-9(Hazardous Substances Data)

Upstream product

• 745-65-3 ALPROSTADIL 
• 15457-50-8 p-benzoylaminophenol 

Relevant articles and documents

PROSTAGLANDIN ANALOGS AND USES THEREOF

The present invention relates to pharmaceutical composition for the prevention or treatment of a disease, disorder, or condition associated with Nurr1, including, as an active ingredient, a prostaglandin analog or a pharmaceutically acceptable salt thereof, wherein the compound has excellent effects in inducing Nurr1, and thus, can be useful as a pharmaceutical composition for the prevention or treatment of a disease, disorder, or condition associated with Nurr1, in particular, cancer, autoimmune disease such as rheumatoid arthritis, schizophrenia, manic depression and neurodegenerative disease such as Alzheimers disease or Parkinson's disease.